HLscience Co., Ltd. (KOSDAQ:239610)
South Korea · Delayed Price · Currency is KRW 8,290.00
-50.00 (-0.60%)
At close: Apr 17, 2026
HLscience Revenue
In the year 2025, HLscience had annual revenue of 16.71B KRW, down -5.43%. HLscience had revenue of 2.35B in the quarter ending December 31, 2025, a decrease of -37.19%.
Revenue
16.71B
Revenue Growth
-5.43%
P/S Ratio
2.53
Revenue / Employee
196.54M
Employees
85
Market Cap
42.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.71B | -958.46M | -5.43% |
| Dec 31, 2024 | 17.66B | -7.92B | -30.97% |
| Dec 31, 2023 | 25.59B | -27.17B | -51.50% |
| Dec 31, 2022 | 52.76B | -51.62B | -49.45% |
| Dec 31, 2021 | 104.38B | -38.66B | -27.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korea Arlico Pharm | 201.20B |
| RP Bio | 136.22B |
| Jin Yang Pharmaceutical | 120.69B |
| GeneBioTech Co. ,Ltd | 90.79B |
| Korean Drug | 62.51B |
| ChoA Pharmaceutical Co., LTD. | 59.31B |
| Kyung Nam Pharm | 56.18B |
| Seoul Pharma | 52.15B |